XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422L907. A total of 3 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $638,000 | +8.1% | 153,000 | +5.4% | 0.00% | 0.0% |
| Q2 2021 | $590,000 | +26.9% | 145,100 | +13960.1% | 0.00% | 0.0% |
| Q1 2021 | $465,000 | -32.5% | 1,032 | -26.4% | 0.00% | 0.0% |
| Q4 2020 | $689,000 | +474.2% | 1,402 | +587.3% | 0.00% | – |
| Q3 2020 | $120,000 | – | 204 | +20300.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 1 | -50.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 263,700 | $1,297,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,402 | $689,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |